193 related articles for article (PubMed ID: 26459369)
1. c-MET immunostaining in colorectal carcinoma is associated with local disease recurrence.
Al-Maghrabi J; Emam E; Gomaa W; Saggaf M; Buhmeida A; Al-Qahtani M; Al-Ahwal M
BMC Cancer; 2015 Oct; 15():676. PubMed ID: 26459369
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
3. Expression of clusterin in colorectal carcinoma in relation to clinicopathological criteria.
Gomaa W; Al-Ahwal M; Al-Maghrabi H; Buhmeida A; Al-Qahtani M; Al-Maghrabi B; Al-Maghrabi J
Malays J Pathol; 2017 Dec; 39(3):243-250. PubMed ID: 29279586
[TBL] [Abstract][Full Text] [Related]
4. c-MET Overexpression in Colorectal Cancer: A Poor Prognostic Factor for Survival.
Lee SJ; Lee J; Park SH; Park JO; Lim HY; Kang WK; Park YS; Kim ST
Clin Colorectal Cancer; 2018 Sep; 17(3):165-169. PubMed ID: 29576428
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of PAK-1 is an independent predictor of disease recurrence in colorectal carcinoma.
Al-Maghrabi J; Emam E; Gomaa W; Al-Qaydy D; Al-Maghrabi B; Buhmeida A; Abuzenadah A; Al-Qahtani M; Al-Ahwal M
Int J Clin Exp Pathol; 2015; 8(12):15895-902. PubMed ID: 26884861
[TBL] [Abstract][Full Text] [Related]
6. Expression of leptin in colorectal adenocarcinoma showed significant different survival patterns associated with tumor size, lymphovascular invasion, distant metastasis, local recurrence, and relapse of disease in the western province of Saudi Arabia.
Al-Maghrabi JA; Qureshi IA; Khabaz MN
Medicine (Baltimore); 2018 Aug; 97(34):e12052. PubMed ID: 30142858
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach.
Assidi M; Gomaa W; Jafri M; Hanbazazh M; Al-Ahwal M; Pushparaj P; Al-Harbi A; Al-Qahtani M; Buhmeida A; Al-Maghrabi J
Tumour Biol; 2019 Sep; 41(9):1010428319863627. PubMed ID: 31500540
[TBL] [Abstract][Full Text] [Related]
8. FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
Garouniatis A; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Int J Colorectal Dis; 2013 Jan; 28(1):9-18. PubMed ID: 22733437
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of VEGFR1/Flt-1 immunoexpression in colorectal carcinoma.
Al-Maghrabi J; Gomaa W; Buhmeida A; Qari Y; Al-Qahtani M; Al-Ahwal M
Tumour Biol; 2014 Sep; 35(9):9045-51. PubMed ID: 24908415
[TBL] [Abstract][Full Text] [Related]
10. The clinical significance of forkhead box protein A1 and its role in colorectal cancer.
Ma W; Jiang J; Li M; Wang H; Zhang H; He X; Huang L; Zhou Q
Mol Med Rep; 2016 Sep; 14(3):2625-31. PubMed ID: 27484093
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of c-MET expression and mutational status in patients with colorectal cancer lung metastases.
Schweiger T; Starkl V; Glueck O; Glogner C; Traxler D; Jedamzik J; Liebmann-Reindl S; Birner P; Streubel B; Klepetko W; Hoetzenecker K
Eur J Cardiothorac Surg; 2016 Apr; 49(4):1103-11; discussion 1111. PubMed ID: 26503729
[TBL] [Abstract][Full Text] [Related]
12. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
[TBL] [Abstract][Full Text] [Related]
13. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
15. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
16. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
17. c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.
Takeuchi H; Bilchik A; Saha S; Turner R; Wiese D; Tanaka M; Kuo C; Wang HJ; Hoon DS
Clin Cancer Res; 2003 Apr; 9(4):1480-8. PubMed ID: 12684423
[TBL] [Abstract][Full Text] [Related]
18. Spalt-like transcription factor 4 as a potential diagnostic and prognostic marker of colorectal cancer.
Wu HK; Liu C; Fan XX; Wang H; Zhou L
Cancer Biomark; 2017 Aug; 20(2):191-198. PubMed ID: 28869451
[TBL] [Abstract][Full Text] [Related]
19. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
[TBL] [Abstract][Full Text] [Related]
20. Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.
Lu Y; Jingyan G; Baorong S; Peng J; Xu Y; Cai S
Cancer Biomark; 2012; 11(5):219-26. PubMed ID: 23220854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
